North America Anatomic Pathology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product and Service (Instruments, Consumables, and Services), Application (Disease Diagnosis, Drug Discovery and Development, and Others), and End User (Hospitals, Research Laboratories, Diagnostic Laboratories, and Others)
Market Introduction
The anatomic pathology is a significant part of the study and treatment of the diseases. Anatomic pathology is a broad field that includes decedent pathology, surgical pathology, cytopathology, neuropathology, and ophthalmic pathology. The anatomic pathology is usually performed in the medical laboratories of hospitals and diagnostics laboratories.
Get more information on this report : 
Market Overview and Dynamics
The North America anatomic pathology market is expected to reach US$ 13,970.95 million by 2028 from US$ 8,870.41 million in 2021; it is estimated to grow at a CAGR of 6.7% from 2021 to 2028. The growth of the market is attributed to key driving factors such as the increasing prevalence of cancer and other diseases and the growing focus on personalized medicines. However, the lack of skilled professionals and the implementation of stringent government regulations hinder the market growth.
Cancer has a major impact on society across the world. The burden of cancer on healthcare systems is significantly increasing worldwide as it is among the leading causes of death. According to the National Cancer Institute, in 2018, there were 18.1 million new cases and 9.5 million people died from the disease worldwide. ~30% of all premature deaths from noncommunicable diseases among adults aged 30–69 are caused because of cancer. Lung cancer is the most frequently diagnosed cancer in the world. The prevalence of diabetes is growing, especially in the world’s middle-income countries, due to increase in overweight, obesity, and unhealthy diet. Overweight and obesity are among the prime most risk factors causing Type 2 diabetes. According to the IDF Diabetes Atlas Ninth Edition, in 2019, ~463 million adults, from the age range 20–79 years, were living with diabetes; and this number would rise to 700 million. Owing to the increasing prevalence of cancer and other diseases, government agencies, healthcare providers, and institutions are being compelled to contribute toward disease diagnosis and treatment initiatives. Thus, a surge in the prevalence of cancer and other targeted diseases is driving the North America anatomic pathology market growth. Personalized medicines are used in the treatment of diseases such as breast cancer and cardiovascular diseases. The personalized anticancer medicines exhibit fewer and less severe side effects than other types of treatment as they are designed for specific actions. Further, with the ongoing progress in research and clinical studies, personalized medicines are likely to reach even great potential to improve the quality of patient care. Thus, the growing focus on personalized medicines is boosting the anatomic pathology market growth.
The COVID-19 pandemic and the redirection in healthcare resources have impacted every aspect of the diagnostics industry, including the anatomic pathology market. The closure of clinics, operation rooms, and physician offices, and the “stay-at-home” mandates across North America severely impacted the acquisition and submission of specimens for pathology evaluation. In the last two years, the number of patient visits to hospitals has reduced significantly, despite emergency and OPD services being available in hospitals. Further, as most hospitals invested their efforts and resources in diagnosing and treating COVID-19, many planned surgeries were canceled or delayed. As a result, various early cancer detection systems were deactivated, and all autopsies were suspended. According to the World Economic Forum, 28 million elective surgeries and 38% of global cancer surgeries have been delayed. Thus, the number of surgical pathology and cytology samples received in anatomic pathology labs reduced significantly. As a result, the number of diagnostic tests has reduced. The reduction has further reduced the sales of anatomic pathology products during the Q2 of 2020. Moreover, due to the robust increase in COVID- 19 patients, pathology laboratories are now prioritizing and focusing on COVID-19 tests. The rapid increase in the number of infected patients in the US and Canada is likely to hamper the growth of the North America anatomy pathology market in the future. Currently, many countries are relaxing the lockdown restrictions, and most hospitals have resumed elective surgeries. As a result, the number of diagnostic tests is now increasing. However, due to the effects of the COVID-19 pandemic, the overall growth rate of the anatomic pathology market is less than the previous year.
Key Market Segments
Based on product and service, the North America anatomic pathology market is segmented into instruments, consumables, and services. The services segment held the largest share of the market in 2021, whereas the instruments segment is anticipated to register the highest CAGR of the market during the forecast period.
By application, the North America anatomic pathology market is segmented into disease diagnosis, drug discovery and development, and others. The disease diagnosis segment held the largest market share in 2021. However, the drug discovery and development segment is anticipated to register the highest CAGR of the market during 2021–2028.
The North America anatomic pathology market, based on end user, is segmented into hospitals, research laboratories, diagnostic laboratories, and others. The others segment consists of pharmaceutical and biotechnology companies and contract research organizations (CROs). The hospitals segment held the largest share of the market in 2021, and the diagnostic laboratories segment is anticipated to register the highest CAGR of the market during the forecast period.
Major Sources and Companies Listed
A few of the primary and secondary sources referred to while preparing the report on the North America anatomic pathology market are the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and College of American Pathologists (CAP).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of North America anatomic pathology market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the North America anatomic pathology market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America anatomic pathology market.
NORTH AMERICA ANATOMIC PATHOLOGY MARKET SEGMENTATION
By Products and Services
- Services
- Consumables
- Instruments
By Application
- Disease Diagnosis
- Drug Discovery and Development
- Others
By End User
- Hospitals
- Research Laboratories
- Diagnostic Laboratories
- Others
By Country
- US
- Canada
- Mexico
Company Profiles
- F. HOFFMANN-LA ROCHE LTD.
- Danaher
- Hologic, Inc.
- Agilent Technologies, Inc.
- BioGenex
- Diapath S.p.A.
- Bio SB
- MERCK KGaA
- BD
- PHC Holdings Corporation
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Anatomic Pathology Market – By Product and Services
1.3.2 North America Anatomic Pathology Market – By Application
1.3.3 North America Anatomic Pathology Market – By End User
1.3.4 North America Anatomic Pathology Market – By Country
2. Anatomic Pathology Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Anatomic Pathology Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Expert Opinions
5. Anatomic Pathology Market — Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increase in Prevalence of Cancer and Other Diseases
5.1.2 Growing Focus on Personalized Medicines
5.2 Key Market Restraints
5.2.1 Lack of Skilled Professionals
5.2.2 Stringency of Government Regulations
5.3 Key Market Opportunities
5.3.1 Rise in Number of Clinical Trials for Anticancer Drugs
5.4 Future Trends
5.4.1 Development of New Technologies and Launch of Products
5.5 Impact Analysis
6. Anatomic Pathology Market – North America Analysis
6.1 North America Anatomic Pathology Market Revenue Forecast and Analysis
7. Anatomic Pathology Market Analysis – By Product and Service
7.1 Overview
7.2 Anatomic Pathology Market, by Product and Service (2020 and 2028)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Consumables
7.4.1 Overview
7.4.2 Consumables: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Services
7.5.1 Overview
7.5.2 Services: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
8. Anatomic Pathology Market Analysis – By Application
8.1 Overview
8.2 Anatomic Pathology Market, by Application (2020 and 2028)
8.3 Disease Diagnosis
8.3.1 Overview
8.3.2 Disease Diagnosis: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Drug Discovery and Development
8.4.1 Overview
8.4.2 Drug Discovery and Development: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
9. Anatomic Pathology Market Analysis – By End User
9.1 Overview
9.2 Anatomic Pathology Market, by End User (2020 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Research Laboratories
9.4.1 Overview
9.4.2 Research Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
10. Anatomic Pathology Market – North America Analysis
10.1 North America: Anatomic Pathology Market
10.1.1 Overview
10.1.2 North America: Anatomic Pathology Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 US: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 US Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 US Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4 US Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.2 Canada: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Canada: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Canada Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 Canada Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.4 Canada Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.3 Mexico: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Mexico: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Mexico Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 Mexico Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 Mexico Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
11. Impact of COVID-19 Pandemic on Anatomic Pathology Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Anatomic Pathology Market– Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 F. HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Danaher
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Hologic, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Agilent Technologies, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 BioGenex
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Diapath S.p.A.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Bio SB
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 MERCK KGaA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 BD
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 PHC Holdings Corporation
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. US Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 2. US Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 3. US Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 4. Canada Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 5. Canada Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Mexico Anatomic Pathology Market, by Product and Service – Revenue and Forecast to 2028 (USD Million)
Table 8. Mexico Anatomic Pathology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico Anatomic Pathology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 10. Organic Developments Done by Companies
Table 11. Inorganic Developments Done by Companies
Table 12. Glossary of Terms, Anatomic Pathology Market
LIST OF FIGURES
Figure 1. Anatomic Pathology Market Segmentation
Figure 2. Anatomic Pathology Market Segmentation, By Country
Figure 3. Anatomic Pathology Market Overview
Figure 4. Services Segment Held Largest Share of Anatomic Pathology Market
Figure 5. North America Anatomic Pathology Market – Leading Country Markets (US$ Million)
Figure 6. North America PEST Analysis
Figure 7. Global Anatomic Pathology Market Impact Analysis of Drivers and Restraints
Figure 8. North America Anatomic Pathology Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Anatomic Pathology Market Revenue Share, by Product and Service (2020 and 2028)
Figure 10. Instruments: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Consumables: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Services: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Anatomic Pathology Market Revenue Share, by Application (2020 and 2028)
Figure 14. Disease Diagnosis: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Drug Discovery and Development: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Anatomic Pathology Market Revenue Share, by End User (2020 and 2028)
Figure 18. Hospitals: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Research Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Diagnostic Laboratories: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Anatomic Pathology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America: Anatomic Pathology Market, by Key Country – Revenue (2021) (USD Million)
Figure 23. North America: Anatomic Pathology Market, by Country, 2021 & 2028 (%)
Figure 24. US: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. Canada: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Mexico: Anatomic Pathology Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Impact of COVID-19 Pandemic in North American Country Markets
- F. HOFFMANN-LA ROCHE LTD.
- Danaher
- Hologic, Inc.
- Agilent Technologies, Inc.
- BioGenex
- Diapath S.p.A.
- Bio SB
- MERCK KGaA
- BD
- PHC Holdings Corporation
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America anatomic pathology market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America anatomic pathology market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.